The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALECTOR INC | COM | 014442107 | 1,404,000 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | |||
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 1,352,960 | 112,000 | SH | SOLE | 112,000 | 0 | 0 | |||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 1,256,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
| BEAM THERAPEUTICS INC | COM | 07373V105 | 13,204,089 | 476,338 | SH | SOLE | 476,338 | 0 | 0 | |||
| BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 16,770,000 | 2,150,000 | SH | SOLE | 2,150,000 | 0 | 0 | |||
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 4,873,260 | 82,000 | SH | SOLE | 82,000 | 0 | 0 | |||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 23,493,400 | 865,000 | SH | SOLE | 865,000 | 0 | 0 | |||
| CG ONCOLOGY INC | COM | 156944100 | 20,448,600 | 492,500 | SH | SOLE | 492,500 | 0 | 0 | |||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 41,584,685 | 1,170,740 | SH | SOLE | 1,170,740 | 0 | 0 | |||
| CULLINAN THERAPEUTICS INC | COM | 230031106 | 3,208,500 | 310,000 | SH | SOLE | 310,000 | 0 | 0 | |||
| CYTOMX THERAPEUTICS INC | COM | 23284F105 | 2,982,000 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | |||
| DESIGN THERAPEUTICS INC | COM | 25056L103 | 1,950,102 | 207,900 | SH | SOLE | 207,900 | 0 | 0 | |||
| DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | 10,456,862 | 679,900 | SH | SOLE | 679,900 | 0 | 0 | |||
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 744,450 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | |||
| ENGENE HOLDINGS INC | COM | 29286M105 | 1,896,300 | 210,000 | SH | SOLE | 210,000 | 0 | 0 | |||
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 2,021,788 | 58,248 | SH | SOLE | 58,248 | 0 | 0 | |||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 12,940,995 | 801,300 | SH | SOLE | 801,300 | 0 | 0 | |||
| KRYSTAL BIOTECH INC | COM | 501147102 | 5,423,880 | 22,000 | SH | SOLE | 22,000 | 0 | 0 | |||
| LIQUIDIA CORPORATION | COM NEW | 53635D202 | 3,104,100 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | |||
| MBX BIOSCIENCES INC | COM | 55287L101 | 6,654,940 | 211,000 | SH | SOLE | 211,000 | 0 | 0 | |||
| NURIX THERAPEUTICS INC | COM | 67080M103 | 8,726,200 | 460,000 | SH | SOLE | 460,000 | 0 | 0 | |||
| PHARVARIS N V | COM | N69605108 | 13,202,063 | 475,750 | SH | SOLE | 475,750 | 0 | 0 | |||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 3,318,920 | 38,000 | SH | SOLE | 38,000 | 0 | 0 | |||
| RELAY THERAPEUTICS INC | COM | 75943R102 | 4,542,563 | 536,946 | SH | SOLE | 536,946 | 0 | 0 | |||
| SUPERNUS PHARMACEUTICALS INC | COM | 868459108 | 994,000 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | |||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 38,973,550 | 1,855,000 | SH | SOLE | 1,855,000 | 0 | 0 | |||
| TRAVERE THERAPEUTICS INC | COM | 89422G107 | 4,203,100 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | |||
| TYRA BIOSCIENCES INC | COM | 90240B106 | 9,201,500 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | |||
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 5,359,750 | 11,000 | SH | SOLE | 11,000 | 0 | 0 | |||
| UROGEN PHARMA LTD | COM | M96088105 | 2,342,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
| VAXCYTE INC | COM | 92243G108 | 13,449,810 | 291,500 | SH | SOLE | 291,500 | 0 | 0 | |||
| VERA THERAPEUTICS INC | CL A | 92337R101 | 24,433,800 | 482,500 | SH | SOLE | 482,500 | 0 | 0 | |||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 26,720,597 | 858,631 | SH | SOLE | 858,631 | 0 | 0 | |||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 7,613,382 | 447,846 | SH | SOLE | 447,846 | 0 | 0 | |||